Article
BRCA2 gene: a candidate for clinical testing in familial colorectal cancer type X.
Clinical genetics - 1 Jun 2015
Garre P, Martín L, Sanz J, Romero A, Tosar A, Bando I, Llovet P, Diaque P, García-Paredes B, Díaz-Rubio E, de la Hoya M, Caldés T
Abstract excerpt
Familial colorectal cancer type X (FCCX) encompasses a group of families with dominant inheritance pattern of colorectal cancer (CRC) but no alteration in any known CRC susceptibility gene. Therefore, the explanation of their susceptibility is a priority to offer an accurate genetic counseling. We screened the 27 coding exons and exon-intron boundaries of BRCA2 in 48 FCCX probands. We identified 29 variants...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
